5071898 (BLS) News
Track canonical SquawkNews coverage tagged to BLS, 5071898. This hub brings together deduplicated headlines about yhd, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BLS Pharmaceuticals sees FY27 adjusted EBITDA margin 23%-26%
BLS Pharmaceuticals expects FY27 adjusted EBITDA margin in the 23%-26% range.
EARNINGS | Aug 31, 2026, 07:50 AM UTC
M
BLS Pharmaceuticals FY net profit after tax A$15.4 million
BLS Pharmaceuticals reported FY net profit after tax of A$15.4 million.
EQUITY | Aug 31, 2026, 02:41 AM UTC